You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Chembio Diagnostics said today that it has entered a collaboration with biopharma company AstraZeneca to develop a point-of-care diagnostic test that detects an undisclosed biomarker.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.